Single Ascending Dose Study of SRA-444 in Healthy Subjects
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This is a first-in-humans study of SRA-444. This study will provide an initial assessment of
the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of SRA-444 (SR
formulation) after administration of ascending single oral doses to healthy adult subjects.